Loading
AB Science Stock: price and insider trades · France
AB Science: what insiders have been doing
This page follows insider dealings at AB Science as filed with AMF, a company from the Health Care sector. From 18 October 2025 to 18 October 2026, the disclosure feed for AB Science logged 2 filings by 2 insiders.
No insider bought on the market over the period, while 1 insider filed 1 sale totalling €461. At €461, the sale published on 25 May 2026 by Alain Moussy is the largest of the period.
Across the 315 companies tracked on its exchange, the median is 6 filings; at 2 filings, this issuer sits below that mark. Over the whole record (from 2026), the tally stands at no purchases and 1 sale.
A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify.
For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Cytosorbents Corp. Source: insider filings from AMF. Past trades are no guide to future returns.
Insider Decl.
2
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
€461
1 ops. · all time
Who traded when
BuySaleAlain Moussy1 sale
Fundamental score
Ranked 18,988 of 24,148 companies
31.9
score / 100
Value15
Quality49
FCF yld-8.5%
Earn yld-2.9%
EV/EBITDA43.7x
ROE·
Gross mgn83%
Net mgn·
Debt/EBITDA11.3x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€0.56
Analyst consensus
1 analysts0.00/5
€4.49Target €4.49(+701%)€4.49
Income statement
Revenue€1.2M
Gross profit€978k83% margin
EBITDA€1.7M143% margin
Net income-€1.6M-132.6% margin
Valuation
PER (forward)-4.9x
Beta1.23
Balance sheet & cash
Market cap€54.1M
Total debt€19.0M
Free Cash Flow-€4.6M
Profitability & ownership
ROA-22.4%
% insiders47.7%
% institutions0.0%
Last declaration on 17 September 2026
Declarations2 total
245,902 shares@ €0.61100.0% of flowActionEuronext ParisISIN FR00105572642026DD1138624
573 shares@ €0.805100.0% of flowActioncession en bloc hors euronext via la plateforme de negociation electronique BATSISIN FR00105572642026DD1116377
2 of 2 declarations
About AB Science
AB Science is a French biopharmaceutical company focused on developing treatments for serious diseases. It primarily concentrates on therapies based on proteins and monoclonal antibodies.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
